Partial and "complete" adrenergic blockade in posthemorrhagic shock.
D000138:Acidosis / Q000503:physiopathology; D000818:Animals; D001639:Bicarbonates / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D005725:Ganglia, Autonomic / Q000187:drug effects; D006452:Hemoglobinometry; D006863:Hydrogen-Ion Concentration; D008680:Metaraminol / Q000494:pharmacology; D010092:Oximetry; D010101:Oxygen Consumption; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011650:Pulmonary Alveoli / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012756:Sheep; D012771:Shock, Hemorrhagic / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014294:Trimethaphan / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D001639:Bicarbonates; D013565:Sympatholytics; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D002245:Carbon Dioxide; D014294:Trimethaphan; D008680:Metaraminol; D011433:Propranolol